Preclinical and Clinical Applications of Metabolomics and Proteomics in Glioblastoma Research

Glioblastoma (GB) is a primary malignancy of the central nervous system that is classified by the WHO as a grade IV astrocytoma. Despite decades of research, several aspects about the biology of GB are still unclear. Its pathogenesis and resistance mechanisms are poorly understood, and methods to op...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of molecular sciences Vol. 24; no. 1; p. 348
Main Authors Ahmed, Munazza, Semreen, Ahlam M, El-Huneidi, Waseem, Bustanji, Yasser, Abu-Gharbieh, Eman, Alqudah, Mohammad A Y, Alhusban, Ahmed, Shara, Mohd, Abuhelwa, Ahmad Y, Soares, Nelson C, Semreen, Mohammad H, Alzoubi, Karem H
Format Journal Article
LanguageEnglish
Published Switzerland MDPI 25.12.2022
MDPI AG
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Glioblastoma (GB) is a primary malignancy of the central nervous system that is classified by the WHO as a grade IV astrocytoma. Despite decades of research, several aspects about the biology of GB are still unclear. Its pathogenesis and resistance mechanisms are poorly understood, and methods to optimize patient diagnosis and prognosis remain a bottle neck owing to the heterogeneity of the malignancy. The field of omics has recently gained traction, as it can aid in understanding the dynamic spatiotemporal regulatory network of enzymes and metabolites that allows cancer cells to adjust to their surroundings to promote tumor development. In combination with other omics techniques, proteomic and metabolomic investigations, which are a potent means for examining a variety of metabolic enzymes as well as intermediate metabolites, might offer crucial information in this area. Therefore, this review intends to stress the major contribution these tools have made in GB clinical and preclinical research and highlights the crucial impacts made by the integrative "omics" approach in reducing some of the therapeutic challenges associated with GB research and treatment. Thus, our study can purvey the use of these powerful tools in research by serving as a hub that particularly summarizes studies employing metabolomics and proteomics in the realm of GB diagnosis, treatment, and prognosis.
AbstractList Glioblastoma (GB) is a primary malignancy of the central nervous system that is classified by the WHO as a grade IV astrocytoma. Despite decades of research, several aspects about the biology of GB are still unclear. Its pathogenesis and resistance mechanisms are poorly understood, and methods to optimize patient diagnosis and prognosis remain a bottle neck owing to the heterogeneity of the malignancy. The field of omics has recently gained traction, as it can aid in understanding the dynamic spatiotemporal regulatory network of enzymes and metabolites that allows cancer cells to adjust to their surroundings to promote tumor development. In combination with other omics techniques, proteomic and metabolomic investigations, which are a potent means for examining a variety of metabolic enzymes as well as intermediate metabolites, might offer crucial information in this area. Therefore, this review intends to stress the major contribution these tools have made in GB clinical and preclinical research and highlights the crucial impacts made by the integrative “omics” approach in reducing some of the therapeutic challenges associated with GB research and treatment. Thus, our study can purvey the use of these powerful tools in research by serving as a hub that particularly summarizes studies employing metabolomics and proteomics in the realm of GB diagnosis, treatment, and prognosis.
Author Bustanji, Yasser
Alhusban, Ahmed
Alqudah, Mohammad A Y
Shara, Mohd
Abu-Gharbieh, Eman
Ahmed, Munazza
Semreen, Mohammad H
Abuhelwa, Ahmad Y
Soares, Nelson C
Semreen, Ahlam M
Alzoubi, Karem H
El-Huneidi, Waseem
AuthorAffiliation 3 Department of Basic Medical Sciences, College of Medicine, University of Sharjah, Sharjah 27272, United Arab Emirates
5 School of Pharmacy, The University of Jordan, Amman 11942, Jordan
4 Department of Basic and Clinical Pharmacology, College of Medicine, University of Sharjah, Sharjah 27272, United Arab Emirates
1 Department of Pharmacy Practice and Pharmacotherapeutics, College of Pharmacy, University of Sharjah, Sharjah 27272, United Arab Emirates
8 Department of Medicinal Chemistry, College of Pharmacy, University of Sharjah, Sharjah 27272, United Arab Emirates
6 Department of Clinical Sciences, College of Medicine, University of Sharjah, Sharjah 27272, United Arab Emirates
7 Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid 22110, Jordan
2 Research Institute for Medical Health Sciences, University of Sharjah, Sharjah 27272, United Arab Emirates
AuthorAffiliation_xml – name: 4 Department of Basic and Clinical Pharmacology, College of Medicine, University of Sharjah, Sharjah 27272, United Arab Emirates
– name: 3 Department of Basic Medical Sciences, College of Medicine, University of Sharjah, Sharjah 27272, United Arab Emirates
– name: 1 Department of Pharmacy Practice and Pharmacotherapeutics, College of Pharmacy, University of Sharjah, Sharjah 27272, United Arab Emirates
– name: 8 Department of Medicinal Chemistry, College of Pharmacy, University of Sharjah, Sharjah 27272, United Arab Emirates
– name: 5 School of Pharmacy, The University of Jordan, Amman 11942, Jordan
– name: 7 Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid 22110, Jordan
– name: 2 Research Institute for Medical Health Sciences, University of Sharjah, Sharjah 27272, United Arab Emirates
– name: 6 Department of Clinical Sciences, College of Medicine, University of Sharjah, Sharjah 27272, United Arab Emirates
Author_xml – sequence: 1
  givenname: Munazza
  surname: Ahmed
  fullname: Ahmed, Munazza
  organization: Research Institute for Medical Health Sciences, University of Sharjah, Sharjah 27272, United Arab Emirates
– sequence: 2
  givenname: Ahlam M
  surname: Semreen
  fullname: Semreen, Ahlam M
  organization: Research Institute for Medical Health Sciences, University of Sharjah, Sharjah 27272, United Arab Emirates
– sequence: 3
  givenname: Waseem
  orcidid: 0000-0002-1580-2589
  surname: El-Huneidi
  fullname: El-Huneidi, Waseem
  organization: Department of Basic Medical Sciences, College of Medicine, University of Sharjah, Sharjah 27272, United Arab Emirates
– sequence: 4
  givenname: Yasser
  orcidid: 0000-0003-1315-0609
  surname: Bustanji
  fullname: Bustanji, Yasser
  organization: School of Pharmacy, The University of Jordan, Amman 11942, Jordan
– sequence: 5
  givenname: Eman
  orcidid: 0000-0002-5972-0681
  surname: Abu-Gharbieh
  fullname: Abu-Gharbieh, Eman
  organization: Department of Clinical Sciences, College of Medicine, University of Sharjah, Sharjah 27272, United Arab Emirates
– sequence: 6
  givenname: Mohammad A Y
  surname: Alqudah
  fullname: Alqudah, Mohammad A Y
  organization: Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid 22110, Jordan
– sequence: 7
  givenname: Ahmed
  surname: Alhusban
  fullname: Alhusban, Ahmed
  organization: Research Institute for Medical Health Sciences, University of Sharjah, Sharjah 27272, United Arab Emirates
– sequence: 8
  givenname: Mohd
  surname: Shara
  fullname: Shara, Mohd
  organization: Department of Pharmacy Practice and Pharmacotherapeutics, College of Pharmacy, University of Sharjah, Sharjah 27272, United Arab Emirates
– sequence: 9
  givenname: Ahmad Y
  orcidid: 0000-0002-4182-065X
  surname: Abuhelwa
  fullname: Abuhelwa, Ahmad Y
  organization: Research Institute for Medical Health Sciences, University of Sharjah, Sharjah 27272, United Arab Emirates
– sequence: 10
  givenname: Nelson C
  orcidid: 0000-0003-2331-8532
  surname: Soares
  fullname: Soares, Nelson C
  organization: Department of Medicinal Chemistry, College of Pharmacy, University of Sharjah, Sharjah 27272, United Arab Emirates
– sequence: 11
  givenname: Mohammad H
  orcidid: 0000-0002-0169-7538
  surname: Semreen
  fullname: Semreen, Mohammad H
  organization: Department of Medicinal Chemistry, College of Pharmacy, University of Sharjah, Sharjah 27272, United Arab Emirates
– sequence: 12
  givenname: Karem H
  surname: Alzoubi
  fullname: Alzoubi, Karem H
  organization: Research Institute for Medical Health Sciences, University of Sharjah, Sharjah 27272, United Arab Emirates
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36613792$$D View this record in MEDLINE/PubMed
BookMark eNpVkc9LHDEUx0NRqm5767nMsYduza_JTC4FWVoVLJVSjxJekhfNkplsk9lC__uOrsp6er--fN57fE_IwZhHJOQDo1-E0PQ0rofKJWVUyP4NOWaS8yWlqjvYy4_ISa1rSrngrX5LjoRSTHSaH5Pb64IuxTE6SA2Mvlk9F2ebTZqTKeaxNjk0P3ACm1MeoquPyuuSJ9yVcWzOU8w2QZ3yAM0vrAjF3b8jhwFSxfdPcUFuvn_7vbpYXv08v1ydXS1dy9S0BM-somL-AJnrWisdb73TLAgneWvdPPe2DaFF4XXf2sACig4YBZSM9b1YkMsd12dYm02JA5R_JkM0j41c7gyUKbqExinPpA2CgrIy-AAt1UA7h9orqkI3s77uWJutHdA7HKcC6RX09WSM9-Yu_zW651RSMQM-PQFK_rPFOpkhVocpwYh5Ww3vFNM9U7NjC_J5J3Ul11owvKxh1Dy4a_bdneUf9097ET_bKf4DJkqk1A
CitedBy_id crossref_primary_10_1248_bpb_b24_00073
crossref_primary_10_3390_ijms25021335
crossref_primary_10_3390_ijms25105071
crossref_primary_10_3390_life13091831
crossref_primary_10_3389_fphar_2024_1324001
crossref_primary_10_1016_j_trac_2024_117852
crossref_primary_10_1111_cns_14415
Cites_doi 10.1038/cgt.2016.78
10.1093/neuonc/noaa215.035
10.1158/1541-7786.MCR-17-0680
10.1038/s41591-018-0142-3
10.1007/s00401-017-1671-4
10.3390/proteomes4040029
10.1089/omi.2017.0028
10.1101/gad.210773.112
10.1007/978-3-030-62080-6_6
10.1016/j.ccell.2021.01.006
10.1093/carcin/bgl211
10.1016/j.ccell.2017.03.005
10.1038/nature11287
10.3390/ijms20102576
10.1002/mc.22815
10.1007/s10147-016-0959-z
10.1007/s11011-018-0327-y
10.3390/ijms232213940
10.1007/s11060-022-03964-2
10.1152/ajprenal.00429.2016
10.1001/jamaoncol.2018.1789
10.1016/j.jpba.2013.08.041
10.1038/s41388-022-02294-x
10.1016/S0092-8674(02)00824-3
10.1093/nar/gks1065
10.1373/clinchem.2015.251181
10.3390/cancers13205157
10.3390/ijms20163892
10.3390/cancers13010030
10.1038/s41571-018-0003-5
10.1158/0008-5472.CAN-19-0638
10.1016/j.tcb.2016.11.003
10.3389/fonc.2017.00106
10.3389/fimmu.2021.746168
10.18632/oncotarget.25774
10.1186/s12964-019-0421-8
10.3390/cancers14081984
10.1016/j.injury.2018.09.033
10.1155/2018/5238760
10.3390/metabo9070123
10.1186/1749-8546-8-25
10.1056/NEJMra1011165
10.1186/s12916-021-01929-2
10.1016/j.bbrc.2014.02.041
10.1007/s11060-015-1899-6
10.1093/neuonc/noy150
10.3390/ijms21082660
10.1161/CIRCRESAHA.117.310752
10.1093/nar/gkz555
10.1038/nrc3458
10.1093/noajnl/vdab024.019
10.1093/neuonc/not137
10.1186/s12885-018-4040-3
10.1038/s41598-020-71859-1
10.1007/s00401-010-0725-7
10.1007/s10529-012-0917-4
10.3390/metabo4030807
10.1007/978-1-4419-9863-7
10.1039/C8AY02774A
10.2217/fon.12.113
10.1016/B978-0-12-816063-3.00002-5
10.1016/B978-0-12-800871-3.00006-7
10.4049/jimmunol.172.4.2352
10.1038/s41420-020-0258-3
10.3390/metabo11030133
10.3389/fnins.2020.00783
10.1158/0008-5472.957.65.3
10.1016/S0079-6603(08)60879-X
10.1038/s41467-020-18189-y
10.1038/nprot.2010.108
10.1186/s40478-021-01167-w
10.1158/1078-0432.CCR-07-4995
10.1107/S2059798319006867
10.1054/plef.2001.0336
10.1093/neuonc/now258
10.1038/srep21557
10.1021/acsomega.1c02991
10.1007/s00401-018-1836-9
10.1186/1471-2407-9-27
10.1093/neuonc/noac169
10.1002/cam4.2474
10.1158/1538-7445.AM2022-6058
10.1007/s00401-016-1545-1
10.1074/jbc.M111.260935
10.1038/s41419-020-2449-5
10.2215/CJN.07420619
10.1101/cshperspect.a016758
10.1002/mas.21370
10.1016/j.ebiom.2019.07.039
10.1002/mas.21575
10.3390/cancers13030542
10.1101/mcs.a000588
10.1214/10-AOAS341
10.1038/nrd4360
10.1002/ijc.29293
10.1016/j.ijbiomac.2020.03.243
10.1038/nrm3314
10.1093/neuonc/noaa103
10.1111/febs.13148
10.1172/JCI6909
10.1038/nrc2809
10.1152/ajpendo.00513.2004
10.1586/14737159.8.5.617
10.1002/mrc.4503
10.1016/j.aca.2003.08.048
10.1016/B978-0-12-814919-5.00014-2
10.3390/metabo10030088
10.1016/j.molmet.2019.06.026
10.1186/s13148-018-0598-5
10.1016/j.jprot.2018.02.021
10.1093/neuonc/noab200
10.1038/s41467-021-27667-w
10.1038/s41387-017-0003-z
10.1038/nrd4286
10.1111/cas.14504
10.3390/cancers13061327
10.1093/neuonc/noab106
10.3390/cancers11121875
10.1016/j.ddtec.2015.06.005
10.1021/cr300484s
10.1074/mcp.RA118.000644
10.1016/j.tibs.2015.12.001
10.1016/j.cell.2018.08.038
10.1177/0271678X18808947
10.1186/s40486-017-0049-7
10.1016/j.mrrev.2016.05.005
10.1371/journal.pone.0193799
10.3892/ijo.2016.3658
10.1007/978-3-030-69170-7
10.1111/neup.12671
10.1038/s41416-020-1021-5
10.3892/mmr.2013.1725
10.1038/s41598-020-77535-8
10.1186/s12929-022-00804-3
10.1038/s41568-019-0205-x
10.1039/C6FO00027D
10.1038/s41419-018-1176-7
10.1201/9781003080282
10.1039/C7RA03781C
10.1021/acs.jproteome.8b00801
10.3390/ijms18122677
10.2174/1568009615666150923115439
10.1016/j.ccell.2016.05.005
10.1158/0008-5472.CAN-06-1010
10.3390/biomedicines10010125
10.5772/intechopen.90987
10.1186/s12987-022-00333-z
10.3390/cancers13061287
10.1007/978-1-4614-2074-3
10.3892/ijo.2014.2358
10.1126/science.1160809
10.7150/thno.47057
10.3390/cells9020267
10.1002/mc.22236
10.1038/s41571-018-0002-6
10.18632/oncotarget.26063
10.3390/biomedicines8090310
ContentType Journal Article
Copyright 2022 by the authors. 2022
Copyright_xml – notice: 2022 by the authors. 2022
DBID NPM
AAYXX
CITATION
7X8
5PM
DOA
DOI 10.3390/ijms24010348
DatabaseName PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle PubMed
CrossRef
MEDLINE - Academic
DatabaseTitleList
PubMed
CrossRef

Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1422-0067
ExternalDocumentID oai_doaj_org_article_c6d14bf30a6b4fdfa509a07ce9d606f7
10_3390_ijms24010348
36613792
Genre Journal Article
Review
GrantInformation_xml – fundername: University of Sharjah
  grantid: 2201110362; 2201110155
GroupedDBID ---
29J
2WC
3V.
53G
5GY
5VS
7X7
88E
8FE
8FG
8FH
8FI
8FJ
8G5
A8Z
AADQD
AAFWJ
AAHBH
ABDBF
ABJCF
ABUWG
ACGFO
ACIHN
ACIWK
ACPRK
ADBBV
AEAQA
AENEX
AFKRA
AFZYC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
CCPQU
CS3
D1I
DIK
DU5
DWQXO
E3Z
EBD
EBS
EJD
ESTFP
ESX
F5P
FRP
FYUFA
GNUQQ
GROUPED_DOAJ
GUQSH
GX1
HCIFZ
HH5
HMCUK
HYE
IAO
ITC
KB.
KQ8
LK8
M1P
M2O
M48
M7P
MODMG
M~E
NPM
O5R
O5S
OK1
P2P
PDBOC
PIMPY
PQQKQ
PROAC
PSQYO
RIG
RNS
RPM
TR2
TUS
UKHRP
~8M
AAYXX
AFPKN
CITATION
7X8
5PM
ID FETCH-LOGICAL-c516t-ad1b603034e1c75b4c25dc91f3c425bcad1db5ff5e3d985bf1fe37a10ae411883
IEDL.DBID RPM
ISSN 1422-0067
1661-6596
IngestDate Tue Oct 22 15:10:00 EDT 2024
Tue Sep 17 21:30:07 EDT 2024
Sat Oct 26 00:11:10 EDT 2024
Wed Aug 28 12:32:57 EDT 2024
Wed Oct 16 00:40:53 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords preclinical applications
glioblastoma
pharmacometabolomics
omics
proteomics
clinical applications
metabolomics
biomarkers
Language English
License Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c516t-ad1b603034e1c75b4c25dc91f3c425bcad1db5ff5e3d985bf1fe37a10ae411883
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ORCID 0000-0002-4182-065X
0000-0002-0169-7538
0000-0002-5972-0681
0000-0003-2331-8532
0000-0002-1580-2589
0000-0003-1315-0609
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820403/
PMID 36613792
PQID 2761981610
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_c6d14bf30a6b4fdfa509a07ce9d606f7
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9820403
proquest_miscellaneous_2761981610
crossref_primary_10_3390_ijms24010348
pubmed_primary_36613792
PublicationCentury 2000
PublicationDate 20221225
PublicationDateYYYYMMDD 2022-12-25
PublicationDate_xml – month: 12
  year: 2022
  text: 20221225
  day: 25
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
PublicationTitle International journal of molecular sciences
PublicationTitleAlternate Int J Mol Sci
PublicationYear 2022
Publisher MDPI
MDPI AG
Publisher_xml – name: MDPI
– name: MDPI AG
References ref_94
ref_92
Bao (ref_69) 2006; 66
Bastola (ref_118) 2020; 11
ref_14
Wishart (ref_19) 2013; 41
Wang (ref_63) 2010; 10
ref_133
Schadinger (ref_49) 2005; 288
Shi (ref_51) 2020; 156
ref_95
ref_134
Zhou (ref_152) 2011; 286
McBrayer (ref_93) 2018; 175
Arima (ref_123) 2020; 111
Gowda (ref_27) 2008; 8
Marampon (ref_153) 2014; 44
Filley (ref_131) 2017; 7
Xie (ref_52) 2016; 49
Bailleul (ref_65) 2022; 82
Dhodapkar (ref_79) 1999; 104
Berger (ref_43) 2018; 15
Cui (ref_53) 2016; 7
ref_129
Armitage (ref_20) 2014; 87
ref_25
ref_29
Randall (ref_87) 2020; 80
Was (ref_85) 2019; 11
Zhu (ref_147) 2021; 11
ref_26
Kang (ref_114) 2017; 5
Rose (ref_142) 2021; 12
Li (ref_46) 2020; 44
Colwell (ref_148) 2017; 19
ref_159
ref_71
Spence (ref_151) 2008; 14
Verhoeven (ref_57) 2013; 8
Tsai (ref_62) 2022; 29
Hamanishi (ref_80) 2016; 21
ref_150
ref_77
Poore (ref_90) 2019; 21
ref_76
ref_75
ref_154
Damiano (ref_48) 2020; 14
ref_74
Ge (ref_11) 2018; 9
Verheij (ref_18) 2013; 32
Hu (ref_56) 2013; 35
Contrepois (ref_21) 2016; 62
Leenders (ref_28) 2015; 13
(ref_36) 2003; 497
Pegg (ref_58) 1995; 51
Gollapalli (ref_101) 2017; 21
Chowdhury (ref_54) 2015; 54
Digregorio (ref_107) 2021; 9
Lam (ref_146) 2022; 13
ref_149
Lusczek (ref_158) 2018; 49
(ref_8) 2010; 120
ref_140
Casella (ref_116) 2019; 47
Beishline (ref_60) 2015; 282
ref_89
ref_141
Choi (ref_137) 2018; 17
ref_143
Jansen (ref_115) 2017; 120
Anastasi (ref_144) 2020; 10
Seaman (ref_109) 2017; 31
Rogers (ref_5) 2019; 8
Iorgulescu (ref_132) 2018; 24
Tambe (ref_117) 2006; 28
Esteves (ref_67) 2020; 10
Lin (ref_103) 2022; 157
Steinberger (ref_108) 2004; 172
Argmann (ref_157) 2017; 7
Rajani (ref_78) 2021; 3
Wang (ref_72) 2021; 39
Erasimus (ref_9) 2016; 769
Roberts (ref_122) 2005; 65
Filippakopoulos (ref_84) 2014; 13
Erkan (ref_112) 2017; 24
Hvinden (ref_98) 2019; 18
Zhao (ref_125) 2015; 137
Chaichana (ref_3) 2014; 16
Bernini (ref_44) 2020; 40
Gathungu (ref_37) 2020; 39
Poitras (ref_59) 2015; 125
Zhang (ref_73) 2017; 7
Dastmalchi (ref_81) 2020; 22
Heiland (ref_96) 2018; 16
Maas (ref_110) 2017; 27
Louis (ref_1) 2021; 23
Cantley (ref_68) 2009; 324
Zhu (ref_136) 2018; 9
Clish (ref_16) 2015; 1
Smart (ref_30) 2010; 5
Shen (ref_97) 2018; 57
Zhang (ref_113) 2016; 311
Walker (ref_35) 2016; 54
Quaglio (ref_88) 2019; 17
Ostrom (ref_2) 2021; 23
Semenza (ref_156) 2011; 365
Dubin (ref_42) 2020; 15
Grimes (ref_155) 2020; 123
Uzozie (ref_22) 2018; 189
Lane (ref_121) 2022; 41
Yi (ref_145) 2018; 2018
Almeida (ref_139) 2019; 34
Kampa (ref_86) 2020; 40
Yang (ref_61) 2020; 22
Dahlberg (ref_120) 2022; 19
Lim (ref_130) 2018; 15
Marziali (ref_23) 2016; 6
Ko (ref_55) 2013; 8
Tribe (ref_102) 2021; 6
Leaver (ref_50) 2002; 66
Yu (ref_128) 2013; 27
Gu (ref_15) 2012; 8
Arvanitis (ref_10) 2020; 20
Louis (ref_7) 2016; 131
Mayor (ref_100) 2014; 6
ref_119
Kant (ref_64) 2020; 11
Koch (ref_91) 2020; 6
Liberti (ref_13) 2016; 41
Buser (ref_99) 2019; 46
ref_32
ref_31
Zabaleta (ref_135) 2018; 9
ref_39
ref_38
Patti (ref_24) 2012; 13
Kuehnbaum (ref_17) 2013; 113
Yin (ref_12) 2021; 11
He (ref_33) 2019; 11
Haufroid (ref_66) 2019; 75
Falkenberg (ref_83) 2014; 13
Lenting (ref_160) 2017; 133
Weber (ref_47) 2020; 33
ref_104
ref_106
ref_105
Ostrom (ref_4) 2018; 4
Touaibia (ref_82) 2014; 4
ref_45
Harvey (ref_126) 2013; 13
Neidert (ref_138) 2018; 135
ref_41
Catherman (ref_40) 2014; 445
Karpievitch (ref_34) 2010; 4
Zanconato (ref_127) 2016; 29
Tapon (ref_124) 2002; 110
ref_6
Chen (ref_70) 2012; 488
Saydam (ref_111) 2015; 16
References_xml – volume: 24
  start-page: 38
  year: 2017
  ident: ref_112
  article-title: Extracellular Vesicle-Mediated Suicide MRNA/Protein Delivery Inhibits Glioblastoma Tumor Growth in Vivo
  publication-title: Cancer Gene
  doi: 10.1038/cgt.2016.78
  contributor:
    fullname: Erkan
– volume: 22
  start-page: ii9
  year: 2020
  ident: ref_81
  article-title: BIOM-36. The unique metabolomics based biomarkers of response to immunotherapy for glioblastoma
  publication-title: Neuro Oncol.
  doi: 10.1093/neuonc/noaa215.035
  contributor:
    fullname: Dastmalchi
– volume: 16
  start-page: 655
  year: 2018
  ident: ref_96
  article-title: Microenvironment-Derived Regulation of HIF Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme
  publication-title: Mol. Cancer Res.
  doi: 10.1158/1541-7786.MCR-17-0680
  contributor:
    fullname: Heiland
– volume: 24
  start-page: 1094
  year: 2018
  ident: ref_132
  article-title: Immunotherapy for Glioblastoma: Going Viral
  publication-title: Nat. Med.
  doi: 10.1038/s41591-018-0142-3
  contributor:
    fullname: Iorgulescu
– volume: 133
  start-page: 263
  year: 2017
  ident: ref_160
  article-title: Glioma: Experimental Models and Reality
  publication-title: Acta Neuropathol.
  doi: 10.1007/s00401-017-1671-4
  contributor:
    fullname: Lenting
– ident: ref_74
  doi: 10.3390/proteomes4040029
– volume: 21
  start-page: 275
  year: 2017
  ident: ref_101
  article-title: Tissue Proteome Analysis of Different Grades of Human Gliomas Provides Major Cues for Glioma Pathogenesis
  publication-title: OMICS J. Integr. Biol.
  doi: 10.1089/omi.2017.0028
  contributor:
    fullname: Gollapalli
– volume: 27
  start-page: 355
  year: 2013
  ident: ref_128
  article-title: The Hippo Pathway: Regulators and Regulations
  publication-title: Genes Dev.
  doi: 10.1101/gad.210773.112
  contributor:
    fullname: Yu
– ident: ref_134
  doi: 10.1007/978-3-030-62080-6_6
– volume: 39
  start-page: 509
  year: 2021
  ident: ref_72
  article-title: Proteogenomic and Metabolomic Characterization of Human Glioblastoma
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2021.01.006
  contributor:
    fullname: Wang
– volume: 28
  start-page: 777
  year: 2006
  ident: ref_117
  article-title: Tumor Prone Phenotype of Mice Deficient in a Novel Apoptosis-Inducing Gene, Drs
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/bgl211
  contributor:
    fullname: Tambe
– volume: 31
  start-page: 501
  year: 2017
  ident: ref_109
  article-title: Eradication of Tumors through Simultaneous Ablation of CD276/B7-H3-Positive Tumor Cells and Tumor Vasculature
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2017.03.005
  contributor:
    fullname: Seaman
– volume: 488
  start-page: 522
  year: 2012
  ident: ref_70
  article-title: A Restricted Cell Population Propagates Glioblastoma Growth after Chemotherapy
  publication-title: Nature
  doi: 10.1038/nature11287
  contributor:
    fullname: Chen
– ident: ref_76
  doi: 10.3390/ijms20102576
– volume: 57
  start-page: 1078
  year: 2018
  ident: ref_97
  article-title: Identification of Metabolites in Plasma for Predicting Survival in Glioblastoma
  publication-title: Mol. Carcinog.
  doi: 10.1002/mc.22815
  contributor:
    fullname: Shen
– ident: ref_39
– volume: 21
  start-page: 462
  year: 2016
  ident: ref_80
  article-title: PD-1/PD-L1 Blockade in Cancer Treatment: Perspectives and Issues
  publication-title: Int. J. Clin. Oncol.
  doi: 10.1007/s10147-016-0959-z
  contributor:
    fullname: Hamanishi
– volume: 34
  start-page: 141
  year: 2019
  ident: ref_139
  article-title: Adipocyte Proteome and Secretome Influence Inflammatory and Hormone Pathways in Glioma
  publication-title: Metab. Brain Dis.
  doi: 10.1007/s11011-018-0327-y
  contributor:
    fullname: Almeida
– ident: ref_94
  doi: 10.3390/ijms232213940
– volume: 157
  start-page: 15
  year: 2022
  ident: ref_103
  article-title: Recycling of SLC38A1 to the Plasma Membrane by DSCR3 Promotes Acquired Temozolomide Resistance in Glioblastoma
  publication-title: J. Neurooncol.
  doi: 10.1007/s11060-022-03964-2
  contributor:
    fullname: Lin
– volume: 311
  start-page: F844
  year: 2016
  ident: ref_113
  article-title: Extracellular Vesicles in Diagnosis and Therapy of Kidney Diseases
  publication-title: Am. J. Physiol. Ren. Physiol.
  doi: 10.1152/ajprenal.00429.2016
  contributor:
    fullname: Zhang
– volume: 4
  start-page: 1254
  year: 2018
  ident: ref_4
  article-title: Adult Glioma Incidence and Survival by Race or Ethnicity in the United States From 2000 to 2014
  publication-title: JAMA Oncol.
  doi: 10.1001/jamaoncol.2018.1789
  contributor:
    fullname: Ostrom
– volume: 87
  start-page: 1
  year: 2014
  ident: ref_20
  article-title: Metabolomics in Cancer Biomarker Discovery: Current Trends and Future Perspectives
  publication-title: J. Pharm. Biomed. Anal.
  doi: 10.1016/j.jpba.2013.08.041
  contributor:
    fullname: Armitage
– volume: 41
  start-page: 2749
  year: 2022
  ident: ref_121
  article-title: PDGF-R Inhibition Induces Glioblastoma Cell Differentiation via DUSP1/P38MAPK Signalling
  publication-title: Oncogene
  doi: 10.1038/s41388-022-02294-x
  contributor:
    fullname: Lane
– volume: 110
  start-page: 467
  year: 2002
  ident: ref_124
  article-title: Salvador Promotes Both Cell Cycle Exit and Apoptosis in Drosophila and Is Mutated in Human Cancer Cell Lines
  publication-title: Cell
  doi: 10.1016/S0092-8674(02)00824-3
  contributor:
    fullname: Tapon
– volume: 41
  start-page: D801
  year: 2013
  ident: ref_19
  article-title: HMDB 3.0—The Human Metabolome Database in 2013
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gks1065
  contributor:
    fullname: Wishart
– volume: 62
  start-page: 676
  year: 2016
  ident: ref_21
  article-title: Can Metabolic Profiles Be Used as a Phenotypic Readout of the Genome to Enhance Precision Medicine?
  publication-title: Clin. Chem.
  doi: 10.1373/clinchem.2015.251181
  contributor:
    fullname: Contrepois
– ident: ref_77
  doi: 10.3390/cancers13205157
– ident: ref_45
  doi: 10.3390/ijms20163892
– ident: ref_105
  doi: 10.3390/cancers13010030
– volume: 15
  start-page: 422
  year: 2018
  ident: ref_130
  article-title: Current State of Immunotherapy for Glioblastoma
  publication-title: Nat. Rev. Clin. Oncol.
  doi: 10.1038/s41571-018-0003-5
  contributor:
    fullname: Lim
– volume: 80
  start-page: 1258
  year: 2020
  ident: ref_87
  article-title: Localized Metabolomic Gradients in Patient-Derived Xenograft Models of Glioblastoma
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-19-0638
  contributor:
    fullname: Randall
– volume: 27
  start-page: 172
  year: 2017
  ident: ref_110
  article-title: Extracellular Vesicles: Unique Intercellular Delivery Vehicles
  publication-title: Trends Cell Biol.
  doi: 10.1016/j.tcb.2016.11.003
  contributor:
    fullname: Maas
– volume: 7
  start-page: 106
  year: 2017
  ident: ref_131
  article-title: Immune System, Friend or Foe of Oncolytic Virotherapy?
  publication-title: Front. Oncol.
  doi: 10.3389/fonc.2017.00106
  contributor:
    fullname: Filley
– volume: 12
  start-page: 746168
  year: 2021
  ident: ref_142
  article-title: Surfaceome Proteomic of Glioblastoma Revealed Potential Targets for Immunotherapy
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2021.746168
  contributor:
    fullname: Rose
– volume: 9
  start-page: 31045
  year: 2018
  ident: ref_135
  article-title: Spatial and Temporal Proteome Dynamics of Glioma Cells during Oncolytic Adenovirus Delta-24-RGD Infection
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.25774
  contributor:
    fullname: Zabaleta
– volume: 17
  start-page: 108
  year: 2019
  ident: ref_88
  article-title: 1H-NMR Metabolomics Reveals the Glabrescione B Exacerbation of Glycolytic Metabolism beside the Cell Growth Inhibitory Effect in Glioma
  publication-title: Cell Commun. Signal.
  doi: 10.1186/s12964-019-0421-8
  contributor:
    fullname: Quaglio
– ident: ref_119
  doi: 10.3390/cancers14081984
– volume: 49
  start-page: 2178
  year: 2018
  ident: ref_158
  article-title: Plasma Metabolomics Pilot Study Suggests Age and Sex-Based Differences in the Metabolic Response to Traumatic Injury
  publication-title: Injury
  doi: 10.1016/j.injury.2018.09.033
  contributor:
    fullname: Lusczek
– volume: 2018
  start-page: 5238760
  year: 2018
  ident: ref_145
  article-title: Identification of Key Candidate Proteins and Pathways Associated with Temozolomide Resistance in Glioblastoma Based on Subcellular Proteomics and Bioinformatical Analysis
  publication-title: BioMed Res. Int.
  doi: 10.1155/2018/5238760
  contributor:
    fullname: Yi
– ident: ref_29
  doi: 10.3390/metabo9070123
– volume: 8
  start-page: 25
  year: 2013
  ident: ref_57
  article-title: Phellinus Linteus Polysaccharide Extracts Increase the Mitochondrial Membrane Potential and Cause Apoptotic Death of THP-1 Monocytes
  publication-title: Chin. Med.
  doi: 10.1186/1749-8546-8-25
  contributor:
    fullname: Verhoeven
– volume: 365
  start-page: 537
  year: 2011
  ident: ref_156
  article-title: Oxygen Sensing, Homeostasis, and Disease
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMra1011165
  contributor:
    fullname: Semenza
– ident: ref_159
  doi: 10.1186/s12916-021-01929-2
– volume: 445
  start-page: 683
  year: 2014
  ident: ref_40
  article-title: Top Down Proteomics: Facts and Perspectives
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2014.02.041
  contributor:
    fullname: Catherman
– volume: 125
  start-page: 91
  year: 2015
  ident: ref_59
  article-title: Investigating a Signature of Temozolomide Resistance in GB Cell Lines Using Metabolomics
  publication-title: J. Neurooncol.
  doi: 10.1007/s11060-015-1899-6
  contributor:
    fullname: Poitras
– volume: 21
  start-page: 252
  year: 2019
  ident: ref_90
  article-title: Inhibition of MTORC1 in Pediatric Low-Grade Glioma Depletes Glutathione and Therapeutically Synergizes with Carboplatin
  publication-title: Neuro Oncol.
  doi: 10.1093/neuonc/noy150
  contributor:
    fullname: Poore
– ident: ref_149
  doi: 10.3390/ijms21082660
– volume: 120
  start-page: 1649
  year: 2017
  ident: ref_115
  article-title: Extracellular Vesicles in Cardiovascular Disease: Potential Applications in Diagnosis, Prognosis, and Epidemiology
  publication-title: Circ. Res.
  doi: 10.1161/CIRCRESAHA.117.310752
  contributor:
    fullname: Jansen
– volume: 47
  start-page: 7294
  year: 2019
  ident: ref_116
  article-title: Transcriptome Signature of Cellular Senescence
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkz555
  contributor:
    fullname: Casella
– volume: 13
  start-page: 246
  year: 2013
  ident: ref_126
  article-title: The Hippo Pathway and Human Cancer
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc3458
  contributor:
    fullname: Harvey
– volume: 3
  start-page: i5
  year: 2021
  ident: ref_78
  article-title: BIMG-20. Metabolic Biomarkers in Microdialysate of IDH-1 Mutant Tumors
  publication-title: Neuro-Oncol. Adv.
  doi: 10.1093/noajnl/vdab024.019
  contributor:
    fullname: Rajani
– volume: 16
  start-page: 113
  year: 2014
  ident: ref_3
  article-title: Establishing Percent Resection and Residual Volume Thresholds Affecting Survival and Recurrence for Patients with Newly Diagnosed Intracranial Glioblastoma
  publication-title: Neuro Oncol.
  doi: 10.1093/neuonc/not137
  contributor:
    fullname: Chaichana
– ident: ref_89
  doi: 10.1186/s12885-018-4040-3
– volume: 10
  start-page: 14868
  year: 2020
  ident: ref_67
  article-title: Probability Distribution of Copy Number Alterations along the Genome: An Algorithm to Distinguish Different Tumour Profiles
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-020-71859-1
  contributor:
    fullname: Esteves
– volume: 120
  start-page: 297
  year: 2010
  ident: ref_8
  article-title: Interobserver Variation of the Histopathological Diagnosis in Clinical Trials on Glioma: A Clinician’s Perspective
  publication-title: Acta Neuropathol.
  doi: 10.1007/s00401-010-0725-7
– volume: 35
  start-page: 1
  year: 2013
  ident: ref_56
  article-title: Induction of Apoptosis in HepG2 Cells by Polysaccharide MEP-II from the Fermentation Broth of Morchella Esculenta
  publication-title: Biotechnol. Lett.
  doi: 10.1007/s10529-012-0917-4
  contributor:
    fullname: Hu
– volume: 4
  start-page: 807
  year: 2014
  ident: ref_82
  article-title: Metabolic Effects of Known and Novel HDAC and SIRT Inhibitors in Glioblastomas Independently or Combined with Temozolomide
  publication-title: Metabolites
  doi: 10.3390/metabo4030807
  contributor:
    fullname: Touaibia
– ident: ref_129
  doi: 10.1007/978-1-4419-9863-7
– volume: 11
  start-page: 1436
  year: 2019
  ident: ref_33
  article-title: Comparison of GC-MS/MS and LC-MS/MS for the Analysis of Hormones and Pesticides in Surface Waters: Advantages and Pitfalls
  publication-title: Anal. Methods
  doi: 10.1039/C8AY02774A
  contributor:
    fullname: He
– volume: 8
  start-page: 1207
  year: 2012
  ident: ref_15
  article-title: Metabolic Profiling: Are We En Route to Better Diagnostic Tests for Cancer?
  publication-title: Future Oncol.
  doi: 10.2217/fon.12.113
  contributor:
    fullname: Gu
– ident: ref_31
  doi: 10.1016/B978-0-12-816063-3.00002-5
– ident: ref_32
  doi: 10.1016/B978-0-12-800871-3.00006-7
– volume: 172
  start-page: 2352
  year: 2004
  ident: ref_108
  article-title: Molecular Characterization of Human 4Ig-B7-H3, a Member of the B7 Family with Four Ig-like Domains
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.172.4.2352
  contributor:
    fullname: Steinberger
– volume: 6
  start-page: 20
  year: 2020
  ident: ref_91
  article-title: A Comparative Pharmaco-Metabolomic Study of Glutaminase Inhibitors in Glioma Stem-like Cells Confirms Biological Effectiveness but Reveals Differences in Target-Specificity
  publication-title: Cell Death Discov.
  doi: 10.1038/s41420-020-0258-3
  contributor:
    fullname: Koch
– ident: ref_75
  doi: 10.3390/metabo11030133
– volume: 14
  start-page: 783
  year: 2020
  ident: ref_48
  article-title: Decanoic Acid and Not Octanoic Acid Stimulates Fatty Acid Synthesis in U87MG Glioblastoma Cells: A Metabolomics Study
  publication-title: Front. Neurosci.
  doi: 10.3389/fnins.2020.00783
  contributor:
    fullname: Damiano
– volume: 65
  start-page: 957
  year: 2005
  ident: ref_122
  article-title: Antiangiogenic and Antitumor Activity of a Selective PDGFR Tyrosine Kinase Inhibitor, CP-673,451
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.957.65.3
  contributor:
    fullname: Roberts
– volume: 51
  start-page: 167
  year: 1995
  ident: ref_58
  article-title: Structure, Function, and Inhibition of O6-Alkylguanine-DNA Alkyltransferase
  publication-title: Prog. Nucleic Acid Res. Mol. Biol.
  doi: 10.1016/S0079-6603(08)60879-X
  contributor:
    fullname: Pegg
– volume: 11
  start-page: 4660
  year: 2020
  ident: ref_118
  article-title: Glioma-Initiating Cells at Tumor Edge Gain Signals from Tumor Core Cells to Promote Their Malignancy
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-020-18189-y
  contributor:
    fullname: Bastola
– volume: 5
  start-page: 1709
  year: 2010
  ident: ref_30
  article-title: Analytical Platform for Metabolome Analysis of Microbial Cells Using Methyl Chloroformate Derivatization Followed by Gas Chromatography-Mass Spectrometry
  publication-title: Nat. Protoc.
  doi: 10.1038/nprot.2010.108
  contributor:
    fullname: Smart
– volume: 9
  start-page: 59
  year: 2021
  ident: ref_107
  article-title: The Expression of B7-H3 Isoforms in Newly Diagnosed Glioblastoma and Recurrence and Their Functional Role
  publication-title: Acta Neuropathol. Commun.
  doi: 10.1186/s40478-021-01167-w
  contributor:
    fullname: Digregorio
– volume: 14
  start-page: 2623
  year: 2008
  ident: ref_151
  article-title: Regional Hypoxia in Glioblastoma Multiforme Quantified with [18F]Fluoromisonidazole Positron Emission Tomography before Radiotherapy: Correlation with Time to Progression and Survival
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-07-4995
  contributor:
    fullname: Spence
– volume: 75
  start-page: 592
  year: 2019
  ident: ref_66
  article-title: Crystal Structures and Snapshots along the Reaction Pathway of Human Phosphoserine Phosphatase
  publication-title: Acta Cryst. D Struct. Biol.
  doi: 10.1107/S2059798319006867
  contributor:
    fullname: Haufroid
– volume: 66
  start-page: 19
  year: 2002
  ident: ref_50
  article-title: Antitumour and Pro-Apoptotic Actions of Highly Unsaturated Fatty Acids in Glioma
  publication-title: Prostaglandins Leukot. Essent. Fat. Acids
  doi: 10.1054/plef.2001.0336
  contributor:
    fullname: Leaver
– volume: 19
  start-page: 887
  year: 2017
  ident: ref_148
  article-title: Hypoxia in the Glioblastoma Microenvironment: Shaping the Phenotype of Cancer Stem-like Cells
  publication-title: Neuro Oncol.
  doi: 10.1093/neuonc/now258
  contributor:
    fullname: Colwell
– volume: 6
  start-page: 21557
  year: 2016
  ident: ref_23
  article-title: Metabolic/Proteomic Signature Defines Two Glioblastoma Subtypes With Different Clinical Outcome
  publication-title: Sci. Rep.
  doi: 10.1038/srep21557
  contributor:
    fullname: Marziali
– volume: 6
  start-page: 24535
  year: 2021
  ident: ref_102
  article-title: The Big Picture of Glioblastoma Malignancy: A Meta-Analysis of Glioblastoma Proteomics to Identify Altered Biological Pathways
  publication-title: ACS Omega
  doi: 10.1021/acsomega.1c02991
  contributor:
    fullname: Tribe
– volume: 135
  start-page: 923
  year: 2018
  ident: ref_138
  article-title: The Natural HLA Ligandome of Glioblastoma Stem-like Cells: Antigen Discovery for T Cell-Based Immunotherapy
  publication-title: Acta Neuropathol.
  doi: 10.1007/s00401-018-1836-9
  contributor:
    fullname: Neidert
– ident: ref_14
  doi: 10.1186/1471-2407-9-27
– ident: ref_106
  doi: 10.1093/neuonc/noac169
– volume: 8
  start-page: 5574
  year: 2019
  ident: ref_5
  article-title: Are 90% of Deaths from Cancer Caused by Metastases?
  publication-title: Cancer Med.
  doi: 10.1002/cam4.2474
  contributor:
    fullname: Rogers
– volume: 44
  start-page: e13140
  year: 2020
  ident: ref_46
  article-title: Ketogenic Diets and Protective Mechanisms in Epilepsy, Metabolic Disorders, Cancer, Neuronal Loss, and Muscle and Nerve Degeneration
  publication-title: J. Food Biochem.
  contributor:
    fullname: Li
– volume: 82
  start-page: 6058
  year: 2022
  ident: ref_65
  article-title: Abstract 6058: The Serine Synthesis Pathway Contributes to the Radiation-Induced Metabolic Plasticity in Glioblastoma Multiforme
  publication-title: Cancer Res.
  doi: 10.1158/1538-7445.AM2022-6058
  contributor:
    fullname: Bailleul
– volume: 131
  start-page: 803
  year: 2016
  ident: ref_7
  article-title: The 2016 World Health Organization Classification of Tumors of the Central Nervous System: A Summary
  publication-title: Acta Neuropathol.
  doi: 10.1007/s00401-016-1545-1
  contributor:
    fullname: Louis
– volume: 286
  start-page: 32843
  year: 2011
  ident: ref_152
  article-title: Metabolic Alterations in Highly Tumorigenic Glioblastoma Cells
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M111.260935
  contributor:
    fullname: Zhou
– volume: 11
  start-page: 253
  year: 2020
  ident: ref_64
  article-title: Enhanced Fatty Acid Oxidation Provides Glioblastoma Cells Metabolic Plasticity to Accommodate to Its Dynamic Nutrient Microenvironment
  publication-title: Cell Death Dis.
  doi: 10.1038/s41419-020-2449-5
  contributor:
    fullname: Kant
– volume: 15
  start-page: 404
  year: 2020
  ident: ref_42
  article-title: Proteomics and Metabolomics in Kidney Disease, Including Insights into Etiology, Treatment, and Prevention
  publication-title: Clin. J. Am. Soc. Nephrol.
  doi: 10.2215/CJN.07420619
  contributor:
    fullname: Dubin
– volume: 6
  start-page: a016758
  year: 2014
  ident: ref_100
  article-title: Clathrin-Independent Pathways of Endocytosis
  publication-title: Cold Spring Harb. Perspect. Biol.
  doi: 10.1101/cshperspect.a016758
  contributor:
    fullname: Mayor
– volume: 32
  start-page: 399
  year: 2013
  ident: ref_18
  article-title: Looking Back into the Future: 30 Years of Metabolomics at TNO
  publication-title: Mass. Spec. Rev.
  doi: 10.1002/mas.21370
  contributor:
    fullname: Verheij
– volume: 46
  start-page: 32
  year: 2019
  ident: ref_99
  article-title: Quantitative Proteomics Reveals Reduction of Endocytic Machinery Components in Gliomas
  publication-title: EBioMedicine
  doi: 10.1016/j.ebiom.2019.07.039
  contributor:
    fullname: Buser
– volume: 39
  start-page: 35
  year: 2020
  ident: ref_37
  article-title: The Integration of LC-MS and NMR for the Analysis of Low Molecular Weight Trace Analytes in Complex Matrices
  publication-title: Mass. Spec. Rev.
  doi: 10.1002/mas.21575
  contributor:
    fullname: Gathungu
– ident: ref_150
  doi: 10.3390/cancers13030542
– volume: 1
  start-page: a000588
  year: 2015
  ident: ref_16
  article-title: Metabolomics: An Emerging but Powerful Tool for Precision Medicine
  publication-title: Cold Spring Harb. Mol. Case Stud.
  doi: 10.1101/mcs.a000588
  contributor:
    fullname: Clish
– volume: 4
  start-page: 1797
  year: 2010
  ident: ref_34
  article-title: Liquid Chromatography Mass Spectrometry-Based Proteomics: Biological and Technological Aspects
  publication-title: Ann. Appl. Stat.
  doi: 10.1214/10-AOAS341
  contributor:
    fullname: Karpievitch
– volume: 13
  start-page: 673
  year: 2014
  ident: ref_83
  article-title: Histone Deacetylases and Their Inhibitors in Cancer, Neurological Diseases and Immune Disorders
  publication-title: Nat. Rev. Drug Discov.
  doi: 10.1038/nrd4360
  contributor:
    fullname: Falkenberg
– volume: 137
  start-page: 2767
  year: 2015
  ident: ref_125
  article-title: The Hippo Pathway in Chemotherapeutic Drug Resistance: Hippo Pathway and Drug Resistance
  publication-title: Int. J. Cancer
  doi: 10.1002/ijc.29293
  contributor:
    fullname: Zhao
– volume: 156
  start-page: 471
  year: 2020
  ident: ref_51
  article-title: The Effect of Polysaccharides from Cibotium Barometz on Enhancing Temozolomide–Induced Glutathione Exhausted in Human Glioblastoma U87 Cells, as Revealed by 1H NMR Metabolomics Analysis
  publication-title: Int. J. Biol. Macromol.
  doi: 10.1016/j.ijbiomac.2020.03.243
  contributor:
    fullname: Shi
– volume: 13
  start-page: 263
  year: 2012
  ident: ref_24
  article-title: Innovation: Metabolomics: The Apogee of the Omics Trilogy
  publication-title: Nat. Rev. Mol. Cell Biol.
  doi: 10.1038/nrm3314
  contributor:
    fullname: Patti
– volume: 22
  start-page: 1439
  year: 2020
  ident: ref_61
  article-title: Increased Activation of HDAC1/2/6 and Sp1 Underlies Therapeutic Resistance and Tumor Growth in Glioblastoma
  publication-title: Neuro Oncol.
  doi: 10.1093/neuonc/noaa103
  contributor:
    fullname: Yang
– volume: 282
  start-page: 224
  year: 2015
  ident: ref_60
  article-title: Sp1 and the “Hallmarks of Cancer"
  publication-title: FEBS J.
  doi: 10.1111/febs.13148
  contributor:
    fullname: Beishline
– volume: 104
  start-page: 173
  year: 1999
  ident: ref_79
  article-title: Rapid Generation of Broad T-Cell Immunity in Humans after a Single Injection of Mature Dendritic Cells
  publication-title: J. Clin. Investig.
  doi: 10.1172/JCI6909
  contributor:
    fullname: Dhodapkar
– volume: 10
  start-page: 181
  year: 2010
  ident: ref_63
  article-title: Eicosanoids and Cancer
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc2809
  contributor:
    fullname: Wang
– volume: 288
  start-page: E1195
  year: 2005
  ident: ref_49
  article-title: PPARgamma2 Regulates Lipogenesis and Lipid Accumulation in Steatotic Hepatocytes
  publication-title: Am. J. Physiol. Endocrinol. Metab.
  doi: 10.1152/ajpendo.00513.2004
  contributor:
    fullname: Schadinger
– volume: 8
  start-page: 617
  year: 2008
  ident: ref_27
  article-title: Metabolomics-Based Methods for Early Disease Diagnostics
  publication-title: Expert Rev. Mol. Diagn.
  doi: 10.1586/14737159.8.5.617
  contributor:
    fullname: Gowda
– volume: 54
  start-page: 998
  year: 2016
  ident: ref_35
  article-title: Unambiguous Metabolite Identification in High-Throughput Metabolomics by Hybrid 1D 1 H NMR/ESI MS1 Approach
  publication-title: Magn. Reson. Chem.
  doi: 10.1002/mrc.4503
  contributor:
    fullname: Walker
– volume: 497
  start-page: 1
  year: 2003
  ident: ref_36
  article-title: Advantages and Disadvantages of Nuclear Magnetic Resonance Spectroscopy as a Hyphenated Technique
  publication-title: Anal. Chim. Acta
  doi: 10.1016/j.aca.2003.08.048
– ident: ref_38
  doi: 10.1016/B978-0-12-814919-5.00014-2
– ident: ref_95
  doi: 10.3390/metabo10030088
– volume: 33
  start-page: 102
  year: 2020
  ident: ref_47
  article-title: Ketogenic Diet in the Treatment of Cancer—Where Do We Stand?
  publication-title: Mol. Metab.
  doi: 10.1016/j.molmet.2019.06.026
  contributor:
    fullname: Weber
– volume: 11
  start-page: 11
  year: 2019
  ident: ref_85
  article-title: Histone Deacetylase Inhibitors Exert Anti-Tumor Effects on Human Adherent and Stem-like Glioma Cells
  publication-title: Clin. Epigenet.
  doi: 10.1186/s13148-018-0598-5
  contributor:
    fullname: Was
– volume: 189
  start-page: 1
  year: 2018
  ident: ref_22
  article-title: Advancing Translational Research and Precision Medicine with Targeted Proteomics
  publication-title: J. Proteom.
  doi: 10.1016/j.jprot.2018.02.021
  contributor:
    fullname: Uzozie
– volume: 23
  start-page: iii1
  year: 2021
  ident: ref_2
  article-title: CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014–2018
  publication-title: Neuro Oncol.
  doi: 10.1093/neuonc/noab200
  contributor:
    fullname: Ostrom
– volume: 13
  start-page: 116
  year: 2022
  ident: ref_146
  article-title: Topographic Mapping of the Glioblastoma Proteome Reveals a Triple-Axis Model of Intra-Tumoral Heterogeneity
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-021-27667-w
  contributor:
    fullname: Lam
– volume: 7
  start-page: 300
  year: 2017
  ident: ref_157
  article-title: Ethnic Differences in Metabolite Signatures and Type 2 Diabetes: A Nested Case–Control Analysis among People of South Asian, African and European Origin
  publication-title: Nutr. Diabetes
  doi: 10.1038/s41387-017-0003-z
  contributor:
    fullname: Argmann
– volume: 13
  start-page: 337
  year: 2014
  ident: ref_84
  article-title: Targeting Bromodomains: Epigenetic Readers of Lysine Acetylation
  publication-title: Nat. Rev. Drug Discov.
  doi: 10.1038/nrd4286
  contributor:
    fullname: Filippakopoulos
– volume: 111
  start-page: 2689
  year: 2020
  ident: ref_123
  article-title: Targeting of Cancer Stem Cells by Differentiation Therapy
  publication-title: Cancer Sci.
  doi: 10.1111/cas.14504
  contributor:
    fullname: Arima
– ident: ref_71
  doi: 10.3390/cancers13061327
– volume: 23
  start-page: 1231
  year: 2021
  ident: ref_1
  article-title: The 2021 WHO Classification of Tumors of the Central Nervous System: A Summary
  publication-title: Neuro Oncol.
  doi: 10.1093/neuonc/noab106
  contributor:
    fullname: Louis
– ident: ref_92
  doi: 10.3390/cancers11121875
– volume: 13
  start-page: 39
  year: 2015
  ident: ref_28
  article-title: Nuclear Magnetic Resonance: A Key Metabolomics Platform in the Drug Discovery Process
  publication-title: Drug Discov. Today Technol.
  doi: 10.1016/j.ddtec.2015.06.005
  contributor:
    fullname: Leenders
– volume: 113
  start-page: 2437
  year: 2013
  ident: ref_17
  article-title: New Advances in Separation Science for Metabolomics: Resolving Chemical Diversity in a Post-Genomic Era
  publication-title: Chem. Rev.
  doi: 10.1021/cr300484s
  contributor:
    fullname: Kuehnbaum
– volume: 17
  start-page: 1948
  year: 2018
  ident: ref_137
  article-title: The Impact of Oncogenic EGFRvIII on the Proteome of Extracellular Vesicles Released from Glioblastoma Cells
  publication-title: Mol. Cell. Proteom.
  doi: 10.1074/mcp.RA118.000644
  contributor:
    fullname: Choi
– volume: 41
  start-page: 211
  year: 2016
  ident: ref_13
  article-title: The Warburg Effect: How Does It Benefit Cancer Cells?
  publication-title: Trends Biochem. Sci.
  doi: 10.1016/j.tibs.2015.12.001
  contributor:
    fullname: Liberti
– volume: 175
  start-page: 101
  year: 2018
  ident: ref_93
  article-title: Transaminase Inhibition by 2-Hydroxyglutarate Impairs Glutamate Biosynthesis and Redox Homeostasis in Glioma
  publication-title: Cell
  doi: 10.1016/j.cell.2018.08.038
  contributor:
    fullname: McBrayer
– volume: 40
  start-page: 177
  year: 2020
  ident: ref_44
  article-title: Modulation of Cerebral Ketone Metabolism Following Traumatic Brain Injury in Humans
  publication-title: J. Cereb. Blood Flow Metab.
  doi: 10.1177/0271678X18808947
  contributor:
    fullname: Bernini
– volume: 5
  start-page: 15
  year: 2017
  ident: ref_114
  article-title: Methods to Isolate Extracellular Vesicles for Diagnosis
  publication-title: Micro Nano Syst. Lett.
  doi: 10.1186/s40486-017-0049-7
  contributor:
    fullname: Kang
– volume: 769
  start-page: 19
  year: 2016
  ident: ref_9
  article-title: DNA Repair Mechanisms and Their Clinical Impact in Glioblastoma
  publication-title: Mutat. Res. Rev. Mutat. Res.
  doi: 10.1016/j.mrrev.2016.05.005
  contributor:
    fullname: Erasimus
– ident: ref_140
  doi: 10.1371/journal.pone.0193799
– volume: 49
  start-page: 1561
  year: 2016
  ident: ref_52
  article-title: A Novel Polysaccharide Derived from Algae Extract Induces Apoptosis and Cell Cycle Arrest in Human Gastric Carcinoma MKN45 Cells via ROS/JNK Signaling Pathway
  publication-title: Int. J. Oncol.
  doi: 10.3892/ijo.2016.3658
  contributor:
    fullname: Xie
– ident: ref_6
  doi: 10.1007/978-3-030-69170-7
– volume: 40
  start-page: 546
  year: 2020
  ident: ref_86
  article-title: Glioblastoma Multiforme: Metabolic Differences to Peritumoral Tissue and IDH-mutated Gliomas Revealed by Mass Spectrometry Imaging
  publication-title: Neuropathology
  doi: 10.1111/neup.12671
  contributor:
    fullname: Kampa
– volume: 123
  start-page: 1562
  year: 2020
  ident: ref_155
  article-title: Evidence for Hypoxia Increasing the Tempo of Evolution in Glioblastoma
  publication-title: Br J. Cancer
  doi: 10.1038/s41416-020-1021-5
  contributor:
    fullname: Grimes
– volume: 8
  start-page: 1767
  year: 2013
  ident: ref_55
  article-title: Soy Soluble Polysaccharide Induces Apoptosis in HCT-116 Human Colon Cancer Cells via Reactive Oxygen Species Generation
  publication-title: Mol. Med. Rep.
  doi: 10.3892/mmr.2013.1725
  contributor:
    fullname: Ko
– volume: 10
  start-page: 20498
  year: 2020
  ident: ref_144
  article-title: Proteomics Analysis of Serum Small Extracellular Vesicles for the Longitudinal Study of a Glioblastoma Multiforme Mouse Model
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-020-77535-8
  contributor:
    fullname: Anastasi
– volume: 29
  start-page: 21
  year: 2022
  ident: ref_62
  article-title: Reprogramming of Arachidonate Metabolism Confers Temozolomide Resistance to Glioblastoma through Enhancing Mitochondrial Activity in Fatty Acid Oxidation
  publication-title: J. Biomed. Sci.
  doi: 10.1186/s12929-022-00804-3
  contributor:
    fullname: Tsai
– volume: 20
  start-page: 26
  year: 2020
  ident: ref_10
  article-title: The Blood–Brain Barrier and Blood–Tumour Barrier in Brain Tumours and Metastases
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/s41568-019-0205-x
  contributor:
    fullname: Arvanitis
– volume: 7
  start-page: 1616
  year: 2016
  ident: ref_53
  article-title: Pleurotus Nebrodensis Polysaccharide(PN50G) Evokes A549 Cell Apoptosis by the ROS/AMPK/PI3K/AKT/MTOR Pathway to Suppress Tumor Growth
  publication-title: Food Funct.
  doi: 10.1039/C6FO00027D
  contributor:
    fullname: Cui
– volume: 9
  start-page: 1128
  year: 2018
  ident: ref_11
  article-title: Hypoxia-Mediated Mitochondria Apoptosis Inhibition Induces Temozolomide Treatment Resistance through MiR-26a/Bad/Bax Axis
  publication-title: Cell Death Dis.
  doi: 10.1038/s41419-018-1176-7
  contributor:
    fullname: Ge
– ident: ref_26
  doi: 10.1201/9781003080282
– volume: 7
  start-page: 24221
  year: 2017
  ident: ref_73
  article-title: LC-MS-Based Metabolomics Reveals Metabolic Signatures Related to Glioma Stem-like Cell Self-Renewal and Differentiation
  publication-title: RSC Adv.
  doi: 10.1039/C7RA03781C
  contributor:
    fullname: Zhang
– volume: 18
  start-page: 2012
  year: 2019
  ident: ref_98
  article-title: Nuclear Magnetic Resonance Spectroscopy to Identify Metabolite Biomarkers of Nonresponsiveness to Targeted Therapy in Glioblastoma Tumor Stem Cells
  publication-title: J. Proteome Res.
  doi: 10.1021/acs.jproteome.8b00801
  contributor:
    fullname: Hvinden
– ident: ref_41
  doi: 10.3390/ijms18122677
– volume: 16
  start-page: 34
  year: 2015
  ident: ref_111
  article-title: Extracellular Vesicles as Novel Delivery Tools for Cancer Treatment
  publication-title: CCDT
  doi: 10.2174/1568009615666150923115439
  contributor:
    fullname: Saydam
– volume: 29
  start-page: 783
  year: 2016
  ident: ref_127
  article-title: YAP/TAZ at the Roots of Cancer
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2016.05.005
  contributor:
    fullname: Zanconato
– volume: 66
  start-page: 7843
  year: 2006
  ident: ref_69
  article-title: Stem Cell–like Glioma Cells Promote Tumor Angiogenesis through Vascular Endothelial Growth Factor
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-06-1010
  contributor:
    fullname: Bao
– ident: ref_141
  doi: 10.3390/biomedicines10010125
– volume: 11
  start-page: 590
  year: 2021
  ident: ref_147
  article-title: P4HA1 as an Unfavorable Prognostic Marker Promotes Cell Migration and Invasion of Glioblastoma via Inducing EMT Process under Hypoxia Microenvironment
  publication-title: Am. J. Cancer Res.
  contributor:
    fullname: Zhu
– ident: ref_25
  doi: 10.5772/intechopen.90987
– volume: 19
  start-page: 45
  year: 2022
  ident: ref_120
  article-title: Glioblastoma Microenvironment Contains Multiple Hormonal and Non-Hormonal Growth-Stimulating Factors
  publication-title: Fluids Barriers CNS
  doi: 10.1186/s12987-022-00333-z
  contributor:
    fullname: Dahlberg
– ident: ref_133
  doi: 10.3390/cancers13061287
– ident: ref_104
  doi: 10.1007/978-1-4614-2074-3
– volume: 44
  start-page: 2121
  year: 2014
  ident: ref_153
  article-title: Hypoxia Sustains Glioblastoma Radioresistance through ERKs/DNA-PKcs/HIF-1α Functional Interplay
  publication-title: Int. J. Oncol.
  doi: 10.3892/ijo.2014.2358
  contributor:
    fullname: Marampon
– volume: 324
  start-page: 1029
  year: 2009
  ident: ref_68
  article-title: Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
  publication-title: Science
  doi: 10.1126/science.1160809
  contributor:
    fullname: Cantley
– volume: 11
  start-page: 1763
  year: 2021
  ident: ref_12
  article-title: Extracellular Vesicles Derived from Hypoxic Glioma Stem-like Cells Confer Temozolomide Resistance on Glioblastoma by Delivering MiR-30b-3p
  publication-title: Theranostics
  doi: 10.7150/thno.47057
  contributor:
    fullname: Yin
– ident: ref_143
  doi: 10.3390/cells9020267
– volume: 54
  start-page: 1636
  year: 2015
  ident: ref_54
  article-title: Low Fucose Containing Bacterial Polysaccharide Facilitate Mitochondria-Dependent ROS-Induced Apoptosis of Human Lung Epithelial Carcinoma via Controlled Regulation of MAPKs-Mediated Nrf2/Keap1 Homeostasis Signaling: Controlled Regulation of Homeostasis Signaling
  publication-title: Mol. Carcinog.
  doi: 10.1002/mc.22236
  contributor:
    fullname: Chowdhury
– volume: 15
  start-page: 353
  year: 2018
  ident: ref_43
  article-title: The Emerging Clinical Relevance of Genomics in Cancer Medicine
  publication-title: Nat. Rev. Clin. Oncol.
  doi: 10.1038/s41571-018-0002-6
  contributor:
    fullname: Berger
– volume: 9
  start-page: 33500
  year: 2018
  ident: ref_136
  article-title: Comparative Proteomic Analysis of Cat Eye Syndrome Critical Region Protein 1- Function in Tumor-Associated Macrophages and Immune Response Regulation of Glial Tumors
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.26063
  contributor:
    fullname: Zhu
– ident: ref_154
  doi: 10.3390/biomedicines8090310
SSID ssj0023259
Score 2.4549522
SecondaryResourceType review_article
Snippet Glioblastoma (GB) is a primary malignancy of the central nervous system that is classified by the WHO as a grade IV astrocytoma. Despite decades of research,...
SourceID doaj
pubmedcentral
proquest
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 348
SubjectTerms clinical applications
glioblastoma
metabolomics
omics
preclinical applications
proteomics
Review
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1JS8QwFA4iCF7E3bpRQY_FZm17VFEHYcSDghcpWXFEW3E6B_-9L00rHRG8eEwTaHhf0ve9vg2hY6s5kADhEqE0GCiWsCSXuUgkVaCwpWNWekNxfCtGD-zmkT8OWn35mLBQHjgI7lQLg5lyNJVCMWecBA0n00zbwgD3diGPPC16Y6oztShp26Rh0D6J4IUIIe8UDPzTycvbFNQYTqnv-TNQRm3N_t-I5s94yYECulpFKx1zjM_CjtfQgq3W0VLoJfm5gZ7u4NvVpTnGsjLxRT84G_io49rFY9sA8q8-HXnarrzztRrCcFLF16-TWgGnbuo3GfeBeZvo4ery_mKUdL0TEs2xaBJpsBJwgSmzWGdcMU240QV2VMMtVRrmjeLOcUtNkXPlsLM0kziVloHNkdMttFjVld1BMVAcKTNClQV6572AzAIvyV2OAQ6TqQid9EIs30OJjBJMCy_scijsCJ17CX-v8YWt2wcAd9nBXf4Fd4SOenxKuAjeuyErW8-mJfE_ZHIgsGmEtgNe36-icA5oVpAIZXNIzu1lfqaaPLfFtgugSCylu_-x-T20THz2BCYJ4ftosfmY2QPgNI06bI_vF0c594A
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Scholars Portal Open Access Journals
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LT9wwEB5Rqkq9VNAXKQWlEj2Gxs8kB4QogqJKIA5diUsV-QmLdpN2N0jw7xnnsdqlHHt07CTWjCfzffF4BmDPGYEgQPpEaoMExVGe5CqXiWIaHbby3KlAFM8v5NmI_7wSV2swVBvtBTh_ltqFelKj2WT__u_DIRr8QWCcSNm_jW-nc3RMJGU8fwEvaUjJFYL4-GI_AWFDWzaNoDdKpChkFwL_z90rzqnN4f8c8HwaP7nkkE434E2PJOOjTvWbsOaqt_Cqqy358A5-X-K3rD_2GKvKxsdD42hpzzqufXzuGlwJk3A8ed6OvAy5G7rmuIp_TMa1Rozd1FMVD4F672F0evLr-CzpaykkRhDZJMoSLdGgGXfEZEJzQ4U1BfHMoNVqg_1WC--FY7bIhfbEO5YpkirHkYPk7AOsV3XltiBGyKNURpl2CPfCriB3iFNynxNvvc10BF8HIZZ_upQZJVKNIOxyWdgRfA8SXowJia7bC_XsuuztpjTSEq49S5XUHJ-vEOCoNDOusEi9fBbBl0E_JRpG2O1Qlavv5iUNP2hyBLRpBB87fS1exXAdsKygEWQrmlyZy2pPNb5pk28XCJl4yj79j8lvw2saTlMQmlDxGdab2Z3bQYzT6N12-T4CdM7-DQ
  priority: 102
  providerName: Scholars Portal
Title Preclinical and Clinical Applications of Metabolomics and Proteomics in Glioblastoma Research
URI https://www.ncbi.nlm.nih.gov/pubmed/36613792
https://search.proquest.com/docview/2761981610
https://pubmed.ncbi.nlm.nih.gov/PMC9820403
https://doaj.org/article/c6d14bf30a6b4fdfa509a07ce9d606f7
Volume 24
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB6SlEIvpe-6j8WF9uisZUmWfEyWbEJhw1Ia2EsxejYuu3bIOof8-4z8CLulp14MsmRbzIw83yeNRgBfneEIAnKf5NogQXEZS6SSeaKoRoetPHMqEMXFZX5xxb6v-OoA-LgXpgvaN7o6rteb47q67mIrbzZmOsaJTZeLWYFui6V0egiHaKAjRR9YFkVA30e4U-Tz0-rPZotei6Q0HPGz43u6FP3_wpV_h0fu-Jv5C3g-AMX4pO_QSzhw9St42h8def8afi3xVzXsaoxVbePZWDjZWZKOGx8vXIuKXofdx9uu5TKkZuiLVR2fr6tGI4Rum42Kxzi8N3A1P_s5u0iGoxISw0neJsoSneN4pcwRI7hmJuPWFMRTg4NSG6y3mnvPHbWF5NoT76hQJFWOIcWQ9C0c1U3t3kOMiEYpkVHtEM2FRT_mEIZIL4m33godwbdRiOVNnxGjRCYRhF3uCjuC0yDhxzYhj3V3o7n9XQ7aLE1uCdOepirXDN-vEL-oVBhXWGRWXkTwZdRPiXYfFjNU7Zq7bZmF-ReJeDWN4F2vr8dPUQQdVBRZBGJPk3t92a9BU-tyaw-m9eG_n_wIz7KwQ4JkScY_wVF7e-c-I25p9QStdSXwKufnE3hyena5_DHp5gDwumBy0tnxA755-FM
link.rule.ids 230,315,730,783,787,867,888,2109,2228,24332,27938,27939,31734,33388,33759,53806,53808
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIgQXyrOEZ5DgmN04fiQ5tivKAt1qDy3qBUV-0sBuUnWzB_j1jPOodisucHTsJE7G4_k-e2YM8M5qjiBAuEgojQTFJizKZCYiSRUabOmYlZ4ozk7E9Ix9PufnO8CHWJjWaV-rclQtlqOqvGh9Ky-Xejz4iY3ns0mOZovFdHwLbqO-xmIg6T3PogjpOx93iox-XP5YrtBukZj6Q342rE-bpP9vyPKmg-SGxTnag69DXztHk5-jdaNG-veNNI7__DEP4H6PQcODrvoh7NjqEdzpTqX89Ri-zXEW7AMmQ1mZcDIUDjZ2u8PahTPb4Bha-MDmVdty7rM-dMWyCj8uylohOm_qpQwHF78ncHb04XQyjfpTGCLNiWgiaYgSOBVQZolOuWI64UbnxFGN-q401hvFneOWmjzjyhFnaSpJLC1D9pLRp7Bb1ZV9BiGCJSnThCqLQNHvJzKLCCdzGXHGmVQF8H6QTnHZJdsokKR4KRabUgzg0Ivuuo1Pkd1eqK--F_2_LbQwhClHYykUw-dLhEYyTrXNDZI2lwbwdhB8gSrl90lkZev1qkj80k6GUDgOYL8bCNevoohnaJonAaRbQ2SrL9s1KPg2bXcv6Of_fecbuDs9nR0Xx59OvryAe4kPxCBJlPCXsNtcre0rhEeNet0qwx9D1BUe
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5BEYgLb0oojyDBMZs4tvM4loWlPLbaA5UqJBT5SQO7yaqbPcCv7ziPKltx6tGxkzgZj-f77PEMwFujOIKAxAaJVEhQTMyCTGRJIKhEgy0sM8IRxflxcnTCvpzy01Gqr9ZpX8lyUi1Xk6o8a30r1ysVDn5i4WI-zdFssYiGa23Dm3ALdTbKBqLecy2KsL7zc6fI6sPy92qDtotE1CX6GVmgNlD__9DlVSfJkdWZ3YcfQ387Z5M_k20jJ-rflVCO1_qgB3Cvx6L-YdfkIdww1SO43WWn_PsYfi5wNuwPTvqi0v50KByOdr392vpz0-BYWroDzpu25cJFf-iKZeV_Wpa1RJTe1CvhD65-T-Bk9vH79CjoszEEipOkCYQmMsEpgTJDVMolUzHXKieWKtR7qbBeS24tN1TnGZeWWENTQSJhGLKYjD6FvaquzDPwETQJkcZUGgSMbl-RGUQ6mc2I1Van0oN3g4SKdRd0o0Cy4iRZjCXpwXsnvss2LlR2e6E-_1X0_7dQiSZMWhqJRDJ8vkCIJKJUmVwjebOpB28G4ReoWm6_RFSm3m6K2C3xZAiJIw_2u8Fw-SqKuIameexBujNMdvqyW4PCb8N398J-fu07X8OdxYdZ8e3z8dcDuBu78xgkDmL-Avaa8615iSipka9afbgA0dwXng
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Preclinical+and+Clinical+Applications+of+Metabolomics+and+Proteomics+in+Glioblastoma+Research&rft.jtitle=International+journal+of+molecular+sciences&rft.au=Munazza+Ahmed&rft.au=Ahlam+M.+Semreen&rft.au=Waseem+El-Huneidi&rft.au=Yasser+Bustanji&rft.date=2022-12-25&rft.pub=MDPI+AG&rft.issn=1661-6596&rft.eissn=1422-0067&rft.volume=24&rft.issue=1&rft.spage=348&rft_id=info:doi/10.3390%2Fijms24010348&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_c6d14bf30a6b4fdfa509a07ce9d606f7
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1422-0067&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1422-0067&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1422-0067&client=summon